๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Possibility of a patch system as a new oral delivery system

โœ Scribed by Sudarat Eaimtrakarn; Y.V Rama Prasad; Shivanand P Puthli; Yukako Yoshikawa; Nobuhito Shibata; Kanji Takada

Book ID
108454178
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
144 KB
Volume
250
Category
Article
ISSN
0378-5173

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetic evaluation of a selegili
Pharmacokinetic evaluation of a selegiline pulsatile oral delivery system
โœ Shashank Rohatagi; Jeffrey S. Barrett; Kimberly E. Dewitt; Denis Lessard; Richar ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 440 KB

Selegiline is a selective, irreversible inhibitor of MAO-B, used in the treatment of Parkinson's disease, either alone or as an adjunct to L-DOPA. The sole recommended dosing regimen is 5 mg given in the morning and at noon with breakfast and lunch. A pulsatile oral dosage form was developed to mimi

EPI-check: a new patch test system
EPI-check: a new patch test system
โœ Thomas Fuchs ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 486 KB